REFRaME-O1/ENGOT-OV79/GOG-3086: A Phase II/III, Open-Label Study Evaluating the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice of Chemotherapy in Women with Relapsed Platinum-Resistant Epithelial Ovarian Cancer Expressing Folate Receptor Alpha
GYNECOLOGIC ONCOLOGY（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined